Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q4 FY26 Earnings Presentation
46 slides from Zota Health Care's earnings presentation, May 23, 2026
Slide 1: Regulation 30 cover letter to NSE
May 23, 2026 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Slide 2: Investor Presentation Q4FY26 / FY26
Investor Presentation Zota Health Care Limited Q4FY26 / FY26
Slide 3: Safe Harbour
This presentation has been prepared by the Zota Health Care Limited (the “Company”) Safe Harbour only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Company Overview
healthcare Itd. Company Overview A zota healthcare Itd.
Slide 5: Zota Healthcare At a Glance
Zota Healthcare At a Glance Financial Highlights (FY26 - Consolidated) Revenue from Operations Zota Health Care Ltd., a Headquartered in Surat and Davaindia, launched in 2017, The strategic business model publicly listed company on employing dedicated is a retail generic pharmacy allows Davaindia to
Slide 6: Our Journey
Our Journey Foundational Steps In Setting Up Formulations Domestic Marketing Export Business Strengthening Core And Pioneering Davaindia 2000 2004 2010 2011 2017 2018 Inaugurated an export- Introduced Davaindia, a private sector Achieved ₹10+ Cr in Export Sales; & 75+ Zota Health Care - Acquired all
Slide 7: Management Profile
Management Profile K e t a nk u m a r Z o t a Moxesh Zota Sujit Paul Chairman And Managing Director Group Chief Executive Officer Non-executive Director Total Experience: 38+ Total Experience: 10+ Total Experience: 23+ • Holds a D-Pharmacy degree • Holds a Bachelor’s degree in pharmacy & • Featured
Slide 8: Company Structure
Company Structure Step down subsidiary Supplying products at ALP* Davaindia Zota Health Care Limited (Listed entity) (Davaindia Health Mart Limited) Procurement in listed entity FOFO Domestic Export COCO (Sales to FOFO# stores) (COCO# stores) FOFO Sales through COCO Sales through Zota Health Care Da
Slide 9: Business Overview
healthcare Itd. Business Overview A zota healthcare Itd.
Slide 10: Business Verticals
Business Verticals DAVAINDIA Revenue contribution (FY26) • A Retail generic pharmacy chain providing quality generic medicines. • Focuses only on private-label products in: 02 Store variants 30% – 90% Others Company Owned Company Operated Savings on medicines as • Medicinal | OTC | Ayurvedic | Cosme
Slide 11: Case Study – Savings on Davaindia margins
Case Study – Savings on Davaindia margins Company marketed by > Indian Pharma MNC 1 Indian Pharma MNC 2 Davaindia Same Tablet with Significant Tablet / Medicine Name Rosuvas – 10 mg Rosubest - 10 Rosuvastatin 10 same molecule savings in margins Molecule Rosuvastatin 10mg Generic Type Branded Generic
Slide 12: DAVAINDIA
d davaindia’ GENERIC PHARMACY DAVAINDIA
Slide 13: Davaindia - Retail Pharmacy Chain data
Davaindia - Retail Pharmacy Chain data Revolutionizing the generic pharmacy industry with affordable, accessible, quality healthcare solutions through retail pharmacies’ chain. 2000+ 2,579* 1,656 923 SKUs Total no. COCO stores FOFO Stores of stores *As of 31st March 2026 • Launched in 2017, Davaindi
Slide 14: Davaindia - Operating Model
Davaindia - Operating Model Davaindia Health Mart Limited has Offers a cluster-based store 2,000+ SKUs with 70% medicinal Cloud-based software and AI- implemented a hyperlocal e-commerce model model, optimizing accessibility products and 30% OTC products, with based tools for real-time supply for on
Slide 15: Davaindia - Eliminating traditional supply chain
Davaindia - Eliminating traditional supply chain By sourcing directly from manufacturers and selling straight to consumers, traditional pharma supply chain is eliminated & the cost benefits are transferred to the consumer Average consumer price ~75% savings Doctors on Davaindia medicines as compared
Slide 16: Strengthening the Visibility: Brand Ambassadors
Strengthening the Visibility Zota Group Welcomes Mr. Mahendra Singh Dhoni & Mr. Suniel Shetty as Brand Ambassador of Davaindia 15
Slide 17: Davaindia – What are COCO Stores
Davaindia – What are COCO Stores COCO stores are modern walk-in stores providing a distinct contrast to traditional counter-based pharmacies enhancing customer satisfaction and loyalty. Rapid Expansion The timeline for launching a new COCO store has been significantly shortened, enabling faster roll
Slide 18: Davaindia – COCO Stores
Davaindia – COCO Stores 17
Slide 19: Davaindia - COCO Stores
Davaindia - COCO Stores States No. of Stores Company-Owned Company-Operated 1,656 West Bengal 515 Operational Uttar Pradesh Operated by wholly-owned 326 subsidiary 21 COCO stores Maharashtra Davaindia Health167 Mart Ltd 44 Delhi 100 59 76 Enhancing Store Kerala 83 100 Economics Haryana 76 2 Rajastha
Slide 20: Davaindia COCO - KPI’s (1/2)
Davaindia COCO - KPI’s (1/2) No. of Stores* Quarterly Footfall in lakhs 1,656 39.8 1,438 34.3 1,207 29.6 986 23.0 852 19.0 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 *As of 31st March 2026 19
Slide 21: Davaindia COCO - KPI’s (2/2)
Davaindia COCO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ ₹ 9,324 ₹ 7,923 ₹ 235 ₹ 231 ₹ 229 ₹ 231 ₹ 6,780 ₹ 227 ₹ 5,290 ₹ 4,297 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 20
Slide 22: Same Store Growth Performance: Period Wise Analysis
Same Store Growth Performance: Period Wise Analysis GMV in ₹lakhs/Month Q4FY25 Q3FY26 Q4FY26 7.08 6.85 6.39 4.70 4.62 4.08 3.27 3.22 2.70 2.83 2.21 2.40 2.62 2.36 2.10 2.19 1.83 1.95 1.72 1.76 1.82 1.42 1.05 1.46 April 25 to Dec 25 9+Months 12+ Months 15 to 18 Months 18 to 21 Months 21 to 30 Months
Slide 23: Davaindia – What are FOFO Stores
Davaindia – What are FOFO Stores Franchisee-Owned Franchisee-Operated Asset-light franchise model (FOFO) FOFO stores employ an asset-light franchise model, contributing to the scalability and accessibility of our product offerings. Smaller Store size FOFO stores are compact and over-the-counter form
Slide 24: Davaindia - FOFO Stores
Davaindia - FOFO Stores States No. of Stores West Bengal 193 Uttar Pradesh 189 16 Odisha 114 Madhya Pradesh 74 2 7 Gujarat 55 15 Maharashtra 40 36 3 Haryana 36 1 29 Rajasthan 33 33 13 923 189 Delhi 29 28 Bihar 28 19 Kerala 20 55 74 9 193 Operational FOFO stores Tripura 19 Jammu & Kashmir 16 1 Uttara
Slide 25: Davaindia FOFO - KPI’s (1/2)
Davaindia FOFO - KPI’s (1/2) No. of Stores Quarterly Footfall 893 923 848 15.3 759 13.9 14.2 730 11.9 12.4 Q4FY25 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 24
Slide 26: Davaindia FOFO - KPI’s (2/2)
Davaindia FOFO - KPI’s (2/2) Quarterly GMV ₹ lakhs Avg. Wallet Spend ₹ 4,711 ₹ 4,249 ₹ 309 ₹ 3,923 ₹ 3,385 ₹ 3,488 ₹ 299 ₹ 285 ₹ 281 ₹ 282 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 Q4 FY25 Q1 FY26 Q2 FY26 Q3FY26 Q4FY26 25
Slide 27: OTC Products and Everyday Herbal acquisition
OTC Over-the-counter products Strategic Acquisition as a Acquired 87.78% stake in the Everyday Herbal Group*, move towards backward licensed by the Khadi and Village Industrial Commission, a integration strategic move towards backward integration. OTC products make up ~30% of the stock keeping units
Slide 28: OTC – Products
OTC — Products A zota
Slide 29: Davaindia is Revolutionizing the Indian Healthcare Scenario
Davaindia is Revolutionizing the Indian Healthcare Scenario ₹45,706 lacs ~60 % Gross Merchandise Value Davaindia Gross Margin in COCO format in FY26 2,579 30-90 % Savings to consumers on Fast growing FOFO & Generic medicines COCO store network* *As of 31st March 2026 25-30 % Mature COCO Stores EBITD
Slide 30: State-Wise Presence of Davaindia Across India
State-Wise Presence of Davaindia Across India (COCO & FOFO Models) States FOFO COCO Total West Bengal 193 515 708 Uttar Pradesh 189 326 515 Maharashtra 40 167 207 Delhi 29 100 129 Odisha 114 2 116 Gujarat 55 57 112 Haryana 36 76 112 Madhya Pradesh 74 29 103 Kerala 20 83 103 Rajasthan 33 61 94 Uttara
Slide 31: Davaindia Competitive Edge
Davaindia Competitive Edge The USP of Davaindia: Affordable, Trustworthy, and Innovative Pharmacy Solutions BENEFITS TO THE CUSTOMERS BENEFITS TO THE FRANCHISEES Medicines priced at low MRP thereby ensuring affordability for the masses Store operations and the supply chain efficiently managed by clo
Slide 32: Healthy Repeats
Healthy Repeats Total Average (in %) With a strong base of 80% repeat customers, Davaindia demonstrates a high level of customer satisfaction 80% and loyalty. Repeat Customers 12% New Customers 08% Lost Customers 31
Slide 33: Higher Chronic category share
Higher Click toChronic edit Master category title share style CATEGORY MIX FY25 CATEGORY MIX FY26 57% 60% 27% 27% 16% 13% Chronic OTC Other Chronic OTC Other Higher chronic share: A significant 60% of our revenue comes from chronic disease category, signalling high realization and retention rates, r
Slide 34: Supply Chain Management
Click Supply to edit ChainMaster Management title style • The Company has outsourced supply chain management to a third-party warehousing & logistics partner. • A state-of-art central warehousing & processing center has been built in Surat, in Phase 1. • Eventually the Company will replicate such in
Slide 35: Domestic Operations
healthcare Itd. Domestic Operations A zota healthcare Itd.
Slide 36: Domestic Operations
Domestic Operations Marketing Value Chain: Domestic marketing has been the oldest business vertical for the FDF Manufacturers Company and has remained its mainstay in the past. Until 2017, WHO-GMP certified this vertical contributed most of the Company’s revenues. This manufacturing partners busines
Slide 37: Export Operations
healthcare Itd. Export Operations A zota healthcare Itd.
Slide 38: Export Operations
Export Operations Dossiers Registered In Global Markets Our Exports business vertical, which started in 2010, serves 1. Benin 15. Sri Lanka clients in over 30 countries, mainly in the CIS, Latin America, 2. Bolivia 16. Swaziland Africa, and Asia. At its plant in Sachin, SEZ, the Company 3. Cambodia
Slide 39: Financial Overview
healthcare Itd. Financial Overview A zota healthcare Itd.
Slide 40: Management Commentary
Management Commentary “FY26 has been a defining year for Zota Health Care Limited, marked by strong execution and accelerated expansion across our Davaindia network. We added 997 new stores, including 804 COCO and 193 FOFO stores marking the highest store addition in the pharma retail segment in a s
Slide 41: Quarterly Revenue Segmentation
Quarterly Revenue Segmentation Business Verticals – Consolidated Revenue bifurcation Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs Everyday Herbal ₹ lakhs 13,148 1,920 1,771 441 443 11,479 1,577 1,234 328 911 801 6,282 Q4 FY25 Q3 FY26 Q4 FY26 Q4 FY25 Q3 FY26 Q4 FY26 Q4 FY25
Slide 42: Annually Financial Snapshot
Annually Financial Snapshot Davaindia ₹ lakhs Domestic Operations ₹ lakhs Export Operations ₹ lakhs 41,741 6,794 3,471 3,190 3,014 6,342 2,467 5,983 2,004 5,950 18,621 5,689 10,356 5,578 4,122 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Davaindia has driven revenue gro
Slide 43: Business Vertical Performance (Consolidated)
Business Vertical Performance (Consolidated) ₹ in lakhs (Consolidated) Q4 FY26 Particulars Business Vertical Consolidated Davaindia Domestic Exports Everyday Others Revenue from Operation 13,147.71 1,919.70 801.15 443.41 5.56 16,317.53 Cost of Goods Sold 4,000.21 1,286.20 368.02 307.28 0.00 5,961.71
Slide 44: Profit & Loss Statement (Consolidated)
Profit & Loss Statement (Consolidated) Particulars Q4FY26 Q3FY26 Q4FY25 FY26 FY25 Export Sales (SEZ) 801.15 910.80 1,233.70 3,471.09 3,190.34 Davaindia Sales 13,147.71 11,479.27 6,281.66 41,741.47 18,621.42 Domestic Sales 1,919.70 1,577.32 1,771.10 6,794.29 6,341.50 Everyday Herbal Group 443.41 327.
Slide 45: Balance Sheet Statement (Consolidated)
Balance Sheet Statement (Consolidated) ₹ in lakhs (Consolidated) As at As at As at As at Assets Equity and Liabilities 31st March 2026 31st March 2025 31st March 2026 31st March 2025 Non-Current Assets (i) Equity Share capital 3,463.26 2,863.50 Property, plant and equipment 14,041.17 5,598.94 (ii) O
Slide 46: Thank You
Thank You "ZOTA HOUSE", 2/896, Hira Modi Street, Siddesh Chawan - Sagrampura, -Surat-395 002 (Gujarat) siddesh.chawan@in.ey.com Ajit Mishra - cszota@zotahealthcare.com ajit.j.mishra@in.ey.com www.zotahealthcare.com 45